Barbara Weber's Insider Trades & SAST Disclosures
Barbara Weber's most recent trade in Tango Therapeutics Inc was a trade of 9,778 Common Stock done at an average price of $3.0 . Disclosure was reported to the exchange on Feb. 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Barbara Weber.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tango Therapeutics Inc | Barbara L. Weber | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.99 per share. | 04 Feb 2025 | 9,778 | 1,631,264 | - | 3.0 | 29,217 | Common Stock |
| Tango Therapeutics Inc | Barbara L. Weber | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 04 Feb 2025 | 9,013 | 1,622,251 | - | 3.2 | 28,494 | Common Stock |
| Tango Therapeutics Inc | Barbara L. Weber | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 635,250 | 635,250 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Barbara L. Weber | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 105,875 | 1,641,042 | - | 0 | Common Stock | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Sale of securities on an exchange or to another person at price $ 48.02 per share. | 08 Oct 2024 | 5,200 | 13,065 (0%) | 0% | 48.0 | 249,716 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Sale or transfer of securities back to the company at price $ 44.83 per share. | 21 Aug 2024 | 1,808 | 18,265 (0%) | 0% | 44.8 | 81,053 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,955 | 15,955 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,800 | 20,625 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,248 | 20,073 (0%) | 0% | 0 | Common Stock | |
| Tango Therapeutics Inc | Barbara L. Weber | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.56 per share. | 06 Feb 2024 | 4,681 | 1,539,624 | - | 12.6 | 58,806 | Common Stock |
| Tango Therapeutics Inc | L. Weber Barbara | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.62 per share. | 06 Feb 2024 | 4,457 | 1,535,167 | - | 12.6 | 56,246 | Common Stock |
| Tango Therapeutics Inc | Barbara L. Weber | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 523,012 | 523,012 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Barbara L. Weber | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 87,168 | 87,168 | - | 0 | Common Stock | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 5,200 | 15,825 (0%) | 0% | 0 | Common Stock | |
| Tango Therapeutics Inc | Barbara L. Weber | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 537,273 | 537,273 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Barbara L. Weber | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 89,545 | 1,457,137 | - | 0 | Common Stock | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 5,200 | 10,625 (0%) | 0% | 0 | Common Stock | |
| Tango Therapeutics Inc | Barbara L. Weber | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 625,000 | 625,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Barbara Weber | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2021 | 961,403 | 961,403 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 12,659 | 12,659 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 3,617 | 5,425 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Barbara Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 5,000 | 12,997 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 04 Feb 2021 | 5,000 | 6,808 (0%) | 0% | 4.7 | 23,650 | Common Stock |
| Revolution Medicines Inc | Barbara Weber | Director | Sale of securities on an exchange or to another person at price $ 50.02 per share. | 04 Feb 2021 | 4,100 | 2,708 (0%) | 0% | 50.0 | 205,096 | Common Stock |
| Revolution Medicines Inc | Barbara Weber | Director | Sale of securities on an exchange or to another person at price $ 51.86 per share. | 04 Feb 2021 | 900 | 1,808 (0%) | 0% | 51.9 | 46,671 | Common Stock |
| Revolution Medicines Inc | Barbara Weber | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 02 Feb 2021 | 5,336 | 1,808 (0%) | 0% | 45 | 240,120 | Common Stock |
| Revolution Medicines Inc | Barbara Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 5,336 | 13,489 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 02 Feb 2021 | 5,336 | 7,144 (0%) | 0% | 1.1 | 5,976 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Sale of securities on an exchange or to another person at price $ 36.17 per share. | 01 Oct 2020 | 7,196 | 1,808 (0%) | 0% | 36.2 | 260,313 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 01 Oct 2020 | 7,196 | 9,004 (0%) | 0% | 1.1 | 8,060 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 7,196 | 18,825 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 2,000 | 26,825 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Sale of securities on an exchange or to another person at price $ 34.76 per share. | 01 Oct 2020 | 2,000 | 1,808 (0%) | 0% | 34.8 | 69,521 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 01 Oct 2020 | 2,000 | 3,808 (0%) | 0% | 1.1 | 2,240 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Sale of securities on an exchange or to another person at price $ 36.02 per share. | 01 Oct 2020 | 804 | 1,808 (0%) | 0% | 36.0 | 28,960 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 01 Oct 2020 | 804 | 2,612 (0%) | 0% | 1.1 | 900 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 804 | 26,021 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 12 Aug 2020 | 1,667 | 3,475 (0%) | 0% | 1.1 | 1,867 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2020 | 1,667 | 29,158 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 12 Aug 2020 | 1,667 | 1,808 (0%) | 0% | 28 | 46,676 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2020 | 333 | 28,825 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 12 Aug 2020 | 333 | 1,808 (0%) | 0% | 28 | 9,324 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 12 Aug 2020 | 333 | 2,141 (0%) | 0% | 1.1 | 373 | Common Stock |
| Revolution Medicines Inc | Barbara L. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 6,329 | 6,329 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Barbara L. Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 1,808 | 1,808 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges